back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-09 12:17 Tx date 2025-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-120,000 vol |
513,000 | |
| Filed 2026-06-09 12:17 Tx date 2024-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-150,000 vol |
300,000 | |
| Filed 2026-06-09 12:15 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-513,000 vol |
0 | |
| Filed 2026-06-09 12:14 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-997,771 vol |
0 | |
| Filed 2026-06-09 12:10 Tx date 2024-01-01 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-45,250 vol |
137,750 | |
| Filed 2026-06-09 12:09 Tx date 2025-01-01 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-48,000 vol |
228,500 | |
| Filed 2026-06-09 12:05 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-228,500 vol |
0 | |
| Filed 2026-06-09 11:54 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-423,000 vol |
0 | |
| Filed 2026-06-09 11:51 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
KISA, LINDA
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-142,500 vol |
0 | |
| Filed 2026-06-09 00:03 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Shannon Trudeau, Deborah
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-97,206.40
-121,508 vol $0.80 each |
0 | |
| Filed 2026-06-09 00:00 Tx date 2024-05-06 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-59,158 vol |
632,000 | |
| Filed 2026-06-09 00:00 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-505,600
-632,000 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:58 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-76,218.40
-95,273 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:56 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-76,218.40
-95,273 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:54 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-76,218.40
-95,273 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:51 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-46,800
-58,500 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:49 Tx date 2024-05-06 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-59,158 vol |
58,500 | |
| Filed 2026-06-08 23:44 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-46,800
-58,500 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:33 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-26,240
-32,800 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:33 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-39,680
-49,600 vol $0.80 each |
0 |